Free Trial

Acasti Pharma (ACST) Earnings Date, Estimates & Call Transcripts

$2.73
+0.03 (+1.11%)
(As of 05/31/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

ACST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Acasti Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.63)($0.63)($0.63)
Q2 20241($0.29)($0.29)($0.29)
Q3 20241($0.30)($0.30)($0.30)
Q4 20241($0.35)($0.35)($0.35)
FY 20244($1.57)($1.57)($1.57)

ACST Earnings Date and Information

Acasti Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off prior year's report dates.

Acasti Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
6/28/2024
(Estimated)
------- 
2/12/2024Q4 2023($0.23)($0.21)+$0.02($0.21)--
11/13/2023Q2 2024($0.29)($0.19)+$0.10$0.05--
8/11/2023Q1 2024($0.63)($0.34)+$0.29($0.14)--
6/23/2023Q4 2023($0.78)($0.30)+$0.48$3.30--
2/14/2023Q3 2023($0.78)($0.54)+$0.24($0.09)--
11/14/2022Q2 2023-($0.66)($0.66)($0.11)--  
8/11/2022Q1 2023-($0.60)($0.60)($0.10)--
6/21/2022Q4 2022($0.78)($0.24)+$0.54($0.04)--
2/14/2022Q3 2022($0.48)($0.54)($0.06)($0.09)--
11/10/2021Q2 2022-$0.18+$0.18$0.03--
8/12/2021Q1 2022-($0.48)($0.48)($0.08)--
6/22/2021Q4 2021-($1.44)($1.44)($0.03)--
2/9/2021Q3 2021-($0.96)($0.96)($0.02)--
11/16/2020Q2 2021($3.36)($2.40)+$0.96($0.05)--
8/13/2020Q2 2020($2.88)($2.40)+$0.48($0.05)--  
6/29/2020Q4 2020($4.32)($2.40)+$1.92($0.23)--  
2/14/2020Q3 2020($6.24)($6.72)($0.48)($0.14)--
11/13/2019Q2 2020($3.84)($3.84)-$0.10--
8/14/2019Q1($5.76)($5.28)+$0.48($0.11)--
6/26/2019Q4 2019($5.28)($8.16)($2.88)($0.17)--

Acasti Pharma Earnings - Frequently Asked Questions

When is Acasti Pharma's earnings date?

Acasti Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, June 28th, 2024 based off last year's report dates. Learn more on ACST's earnings history.

How much profit does Acasti Pharma generate each year?

Acasti Pharma (NASDAQ:ACST) has a recorded net income of -$42.43 million. ACST has generated -$5.08 earnings per share over the last four quarters.

What is Acasti Pharma's EPS forecast for next year?

Acasti Pharma's earnings are expected to grow from ($1.44) per share to ($1.29) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ACST) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners